These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

600 related items for PubMed ID: 12942571

  • 1. Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy.
    Dabaja BS, McLaughlin P, Ha CS, Pro B, Meyers CA, Seabrooke LF, Wilder RB, Kyritsis AP, Preti HA, Yung WK, Levin V, Cabanillas F, Cox JD.
    Cancer; 2003 Sep 01; 98(5):1021-8. PubMed ID: 12942571
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
    Thiel E, Korfel A, Martus P, Kanz L, Griesinger F, Rauch M, Röth A, Hertenstein B, von Toll T, Hundsberger T, Mergenthaler HG, Leithäuser M, Birnbaum T, Fischer L, Jahnke K, Herrlinger U, Plasswilm L, Nägele T, Pietsch T, Bamberg M, Weller M.
    Lancet Oncol; 2010 Nov 01; 11(11):1036-47. PubMed ID: 20970380
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.
    Pöttgen C, Stuschke M, Stüben G, Schmitz A, Schwechheimer K, Wacker HH, Rauhut F, Kleuker S, Wilhelm H, Grehl S, Fehlings T.
    Strahlenther Onkol; 2003 Sep 01; 179(9):626-32. PubMed ID: 14628129
    [Abstract] [Full Text] [Related]

  • 10. Whole-brain radiotherapy and high-dose methylprednisolone for elderly patients with primary central nervous system lymphoma: Results of North Central Cancer Treatment Group (NCCTG) 96-73-51.
    Laack NN, Ballman KV, Brown PB, O'Neill BP, North Central Cancer Treatment Group.
    Int J Radiat Oncol Biol Phys; 2006 Aug 01; 65(5):1429-39. PubMed ID: 16863926
    [Abstract] [Full Text] [Related]

  • 11. Results of treatment of 112 cases of primary CNS lymphoma.
    Yamanaka R, Morii K, Shinbo Y, Homma J, Sano M, Tsuchiya N, Yajima N, Tamura T, Hondoh H, Takahashi H, Kakuma T, Tanaka R.
    Jpn J Clin Oncol; 2008 May 01; 38(5):373-80. PubMed ID: 18413337
    [Abstract] [Full Text] [Related]

  • 12. Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy.
    Pels H, Schmidt-Wolf IG, Glasmacher A, Schulz H, Engert A, Diehl V, Zellner A, Schackert G, Reichmann H, Kroschinsky F, Vogt-Schaden M, Egerer G, Bode U, Schaller C, Deckert M, Fimmers R, Helmstaedter C, Atasoy A, Klockgether T, Schlegel U.
    J Clin Oncol; 2003 Dec 15; 21(24):4489-95. PubMed ID: 14597744
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Response to chemotherapy and treating institution predict survival in primary central nervous system lymphoma.
    Korfel A, Martus P, Nowrousian MR, Hossfeld DK, Kirchen H, Brücher J, Stelljes M, Birkmann J, Peschel C, Pasold R, Fischer L, Jahnke K, Thiel E, German primary central nervous system lymphoma Study Group (G-PCNSL-SG).
    Br J Haematol; 2005 Jan 15; 128(2):177-83. PubMed ID: 15638851
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Primary central nervous system lymphoma--a report of 32 cases with literature review].
    Yi JQ, Lin TY, He YJ, Huang HQ, Xia ZJ, Xia YF, Xu RH, Guo Y, Guan ZZ.
    Ai Zheng; 2006 Apr 15; 25(4):476-80. PubMed ID: 16613684
    [Abstract] [Full Text] [Related]

  • 18. A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma. The GOELAMS LCP 99 trial.
    Olivier G, Clavert A, Lacotte-Thierry L, Gardembas M, Escoffre-Barbe M, Brion A, Cumin I, Legouffe E, Solal-Celigny P, Chabin M, Ingrand P, Colombat P, Delwail V.
    Am J Hematol; 2014 Nov 15; 89(11):1024-9. PubMed ID: 25052698
    [Abstract] [Full Text] [Related]

  • 19. Preliminary results of combined chemotherapy and radiotherapy for non-AIDS primary central nervous system lymphoma. Trans-Tasman Radiation Oncology Group (TROG).
    O'Brien PC, Roos DE, Liew KH, Trotter GE, Barton MB, Walker QJ, Poulsen MG, Olver IN.
    Med J Aust; 1996 Oct 21; 165(8):424-7. PubMed ID: 8913243
    [Abstract] [Full Text] [Related]

  • 20. Chemoradiotherapy for primary CNS lymphoma: an intent-to-treat analysis with complete follow-up.
    Omuro AM, DeAngelis LM, Yahalom J, Abrey LE.
    Neurology; 2005 Jan 11; 64(1):69-74. PubMed ID: 15642906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.